What is new? European Society of Cardiology (ESC) Congress 2026

ESC 2026: Latest guidance for cardiovascular clinical practice and both expected and unexpected results from major clinical trials are reviewed by Dr Tony Dalby, Cardiologist, Johannesburg.
Learning objectives
This 2026 conference report from the European Society of Cardiology
(ESC) provides:
- An update of new ESC guidelines and of clinical trial results across the spectrum of cardiovascular medicine
- The new 2026 ESC guidelines on heart failure are presented with an emphasis on uptitration of medication every two weeks to maximum tolerable doses
- Primary prevention with regard to hypertension, dyslipidaemia and anti-inflammatory therapies is discussed in the light of the results from the most recent trial data.
To access this module, please register or login:
